| Accuracy Evaluation of Five Blood Glucose Monitoring Systems Obtained from the Pharmacy: A European Multicenter Study with 453 Subjects. | |
| | |
MedLine Citation:
|
PMID: 22176154 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Abstract Background: This multicenter study was conducted to evaluate the performance of five recently introduced blood glucose (BG) monitoring (BGM) devices under daily routine conditions in comparison with the YSI (Yellow Springs, OH) 2300 Stat Plus glucose analyzer. Methods: Five hundred one diabetes patients with experience in self-monitoring of BG were randomized to use three of five different BGM devices (FreeStyle Lite(®) [Abbott Diabetes Care Inc., Alameda, CA], FreeStyle Freedom Lite [Abbott Diabetes Care], OneTouch(®) UltraEasy(®) [LifeScan Inc., Milpitas, CA], Accu-Chek(®) Aviva [Roche Diagnostics, Mannheim, Germany], and Contour(®) [Bayer Vital GmbH, Leverkusen, Germany]) in a daily routine setting. All devices and strips were purchased from local regular distribution sources (pharmacies, four strip lots per device). The patients performed the finger prick and the glucose measurement on their own. In parallel, a healthcare professional performed the glucose assessment with the reference method (YSI 2300 Stat Plus). The primary objective was the comparison of the mean absolute relative differences (MARD). Secondary objectives were compliance with the International Organization for Standardization (ISO) accuracy criteria under these routine conditions and Clarke and Parkes Error Grid analyses. Results: MARD ranged from 4.9% (FreeStyle Lite) to 9.7% (OneTouch UltraEasy). The ISO 15197:2003 requirements were fulfilled by the FreeStyle Lite (98.8%), FreeStyle Freedom Lite (97.5%), and Accu-Chek Aviva (97.0%), but not by the Contour (92.4%) and OneTouch UltraEasy (91.1%). The number of values in Zone A of the Clarke Error Grid analysis was highest for the FreeStyle Lite (98.8%) and lowest for the OneTouch Ultra Easy (90.4%). Conclusions: FreeStyle Lite, FreeStyle Freedom Lite, and Accu-Chek Aviva performed very well in this study with devices and strips purchased through regular distribution channels, with the FreeStyle Lite achieving the lowest MARD in this investigation. |
| | |
Authors:
|
Cornelius Tack; Harald Pohlmeier; Thomas Behnke; Volkmar Schmid; Marco Grenningloh; Thomas Forst; Andreas Pfützner |
Related Documents
:
|
9041544 - Arginine reduces kidney collagen accumulation, cross-linking, lipid peroxidation, glyco... 8535614 - Diminished expression of the extracellular domain of bullous pemphigoid antigen 2 (bpag... 9076954 - Apoptosis is increased in a model of diabetes-impaired wound healing in genetically dia... 21707174 - Longitudinal motivational predictors of dietary self-care and diabetes control in adult... 21762204 - Unlicensed use of metformin in children and adolescents in uk. 17558484 - Proinsulin:insulin and insulin:glucose ratios as predictors of carotid plaque growth: a... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-12-16 |
Journal Detail:
|
Title: Diabetes technology & therapeutics Volume: - ISSN: 1557-8593 ISO Abbreviation: - Publication Date: 2011 Dec |
Date Detail:
|
Created Date: 2011-12-19 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100889084 Medline TA: Diabetes Technol Ther Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
1 Radboud University Nijmegen Medical Centre , Nijmegen, The Netherlands . |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Plasmonic Monitoring of Catalytic Hydrogen Generation by a Single Nanoparticle Probe.
Next Document: Role of Bariatric-Metabolic Surgery in the Treatment of Obese Type 2 Diabetes with Body Mass Index <...